Bio-Rad Labs (BIO) Posts Q4 Loss of $0.70/Sh
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $270.32 -3.84%
Revenue Growth %: -4.3%
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: -4.3%
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q4 EPS of ($0.70), which does not compare to the analyst estimate of $1.03. Revenue for the quarter came in at $571.5 million versus the consensus estimate of $570.1 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Worthington Industries (WOR) Misses Q4 EPS by 9c
- SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
